It is likely that the temporal and spatial abundance of GM-CSF, together with the machinery controlling GM-CSF signal strength including receptor expression and regulatory circuitry would dictate the cellular and biological outcome of tumor derived GM-CSF. The gene discussed is CSF2; the disease is neoplasm.